Cervical Cancer Screening for Vulnerable Populations
Dates this webinar will be offered:
This is a one-hour live internet-based activity. To receive continuing education credit, learners should 1) take the pre-test 2) review the webinar and 3) complete the post-test.
By the end of this presentation, you will be able to:
- Describe brief overview of human papillomavirus and current cervical cancer screening guidelines for vulnerable/underserved populations
- Identify vulnerable and underserved populations and describe relevant barriers to cervical cancer screening and treatment.
- Describe and apply ASCCP, ACOG/CDC, and other applicable screening guidelines for vulnerable/underserved populations
- Apply appropriate counseling techniques and patient management for vulnerable/underserved populations
Nurse Practitioners and Nurses: ARHP is approved by the California Board of Registered Nursing, Provider Number 16643, to provide nursing continuing education credits. This live activity is approved for 1.0 contact hour.
Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ARHP designates this internet live activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 Credit™.
This program is sponsored by the Association of Reproductive Health Professionals.
This project and webinar is funded through an independent educational grant from Roche.
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Nikole Gettings, CNM, has nothing to disclose.
Erica Pettigrew, MD, JD, has nothing to disclose.
Shontelle Dixon, MPH, (ARHP program manager) has nothing to disclose.